ANTIPHOSPHOLIPID SYNDROME (APS)
Clinical trials for ANTIPHOSPHOLIPID SYNDROME (APS) explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME (APS) trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME (APS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial offers hope for kids with tough autoimmune conditions
Disease control Not yet recruitingThis early-stage study will test a new cell therapy called YTS109 in 12 children aged 5 to 17 with severe autoimmune diseases like lupus and scleroderma that haven't responded to other treatments. The main goals are to see if the treatment is safe and if it can help control the d…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Phase: PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 17, 2026 10:17 UTC
-
New hope for rare clotting disorder: drug safety trial launches
Disease control Not yet recruitingThis study tests a drug called anifrolumab in 20 adults with antiphospholipid syndrome (APS), a condition that raises the risk of blood clots and pregnancy complications. Participants receive weekly injections for a year alongside their usual treatments. The main goal is to check…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Phase: PHASE2 • Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated May 17, 2026 10:04 UTC